Send to a Friend Share

Illumina's (ILMN) Board Unanimously Rejects Roche's Unsolicited Bid as Inadequate

February 7, 2012 4:06 PM EST
ILMN Hot Sheet
Overall Analyst Rating:
    NEUTRAL (= Flat)

EPS Growth %: +2.9%
Illumina's (Nasdaq: ILMN) Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Mergers and Acquisitions, Rumors

Add Your Comment





Follow StreetInsider.com On Twitter